EWTX (STOCKS)
Edgewise Therapeutics, Inc. Common Stock
$43.180000
-0.380000 (-0.87%)
Prev close: $43.560000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Kevin Koch
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $5,319.99M
- Employees
- 136
- P/E (TTM)
- -23.56
- P/B (TTM)
- 10.48
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
9
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.53 | $-0.48 | -0.0506 | -10.55% |
|
Mar 2026 (Q1)
|
$-0.46 | $-0.50 | +0.0364 | +7.33% |
|
Dec 2025 (Q4)
|
$-0.47 | $-0.44 | -0.0255 | -5.74% |
|
Sep 2025 (Q3)
|
$-0.39 | $-0.41 | +0.0155 | +3.82% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $218.90M |
| Research and Development | $171.27M |
| Other Operating Expenses | $47.62M |
| Operating Income/Loss | -$218.90M |
| Income/Loss From Continuing Operations After Tax | -$197.23M |
| Income/Loss From Continuing Operations Before Tax | -$197.23M |
| Net Income/Loss | -$197.22M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$197.22M |
| Net Income/Loss Available To Common Stockholders, Basic | -$197.22M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.86 |
| Diluted Earnings Per Share | -$1.86 |
| Basic Average Shares | 213,925,892 |
| Diluted Average Shares | 213,925,892 |
| Assets | $479.69M |
| Current Assets | $471.52M |
| Noncurrent Assets | $8.17M |
| Fixed Assets | $6.89M |
| Other Non-current Assets | $1.28M |
| Liabilities | $31.61M |
| Current Liabilities | $29.04M |
| Accounts Payable | $4.67M |
| Wages | $8.58M |
| Other Current Liabilities | $15.80M |
| Noncurrent Liabilities | $2.57M |
| Equity | $448.08M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $448.08M |
| Liabilities And Equity | $479.69M |
| Net Cash Flow From Operating Activities | -$158.38M |
| Net Cash Flow From Operating Activities, Continuing | -$158.38M |
| Net Cash Flow From Investing Activities | $166.40M |
| Net Cash Flow From Investing Activities, Continuing | $166.40M |
| Net Cash Flow From Financing Activities | $20.89M |
| Net Cash Flow From Financing Activities, Continuing | $20.89M |
| Net Cash Flow | $28.92M |
| Net Cash Flow, Continuing | $28.92M |
| Comprehensive Income/Loss | -$197.93M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$197.93M |
| Other Comprehensive Income/Loss | -$704.00K |